| Dermatitis |
1 |
1 |
| Seborrheic Dermatitis |
0 |
0.99 |
| Microbiome |
0 |
0.39 |
| Acne |
0 |
0.3 |
| Face |
0 |
0.24 |
| Scalp |
0 |
0.24 |
| Atopic Dermatitis |
0 |
0.21 |
| Antifungal |
0 |
0.12 |
| Diversity |
0 |
0.12 |
| Eczema |
0 |
0.12 |
| Food and Drug Administration (FDA) |
0 |
0.12 |
| Maryland |
0 |
0.12 |
| New York |
0 |
0.12 |
| Prescription Drugs |
0 |
0.12 |
| Pruritus |
0 |
0.12 |
| Refractory |
0 |
0.12 |
| Vitiligo |
0 |
0.12 |
| Fungal Infection |
0 |
0.08 |
| Skin and Soft Tissue Infection |
0 |
0.08 |
| Social Determinants of Health |
0 |
0.98 |